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A B S T R A C T 
 
 
Introduction: The closure of rural maternity units in Australia means an increasing number of women are transferred into major 
centres to await birth. Accurately excluding the onset of labour could delay relocation. The fetal fibronectin (fFN) test is used to 
predict preterm birth; however, the accuracy of this test for determining impending term birth is unclear. 
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Methods: In all 75 women were recruited to this study from two remote maternity units. Eligibility criteria were: aged ≥18 years, 
singleton pregnancy, 37+0–40+3 weeks (37 weeks to 40 weeks and 3 days gestation) and no indication for induction of labour or 
caesarean section in next 7 days. The Quikcheck fFN® test was performed at 37 weeks and then repeated at 7 day intervals. Time-
to-birth from test date was modelled using linear regression. Logistic regression models estimated odds of birth within 7 days. 
Separate models considered first and last test results and those at 38 weeks; adjusted for use of lubricant and gestational age. 
Results: A shorter time-to-birth was found in women with positive compared with negative fFN tests; significant at first fFN test 
(adjusted mean difference [AMD] 5.4 days, 95% CI 2.0-8.8) and 38 weeks (AMD 5.7 days, 95% CI 2.2-9.2 days). A positive test 
was also associated with a significant increase in the odds of birthing within 7 days: first fFN test adjusted odds ratio (AOR) 11.0 
(95% CI 2.5-48.7), 38 weeks test AOR 14.4 (95% CI 3.4-60.2), last fFN test AOR 8.1 (95% CI 1.6-39.8). However, of women 
who gave birth within 7 days of testing a significant proportion had a negative fFN result; first fFN test 8/17(47.1%), 38 weeks test 
4/14(28.6%) and last fFN test 29/58(50.0%). 
Conclusion: The presence of fFN in cervical secretions was associated with impending term birth but its absence did not reliably 
exclude the onset of birth. Delaying transfer based on these findings would result in some women birthing in their home 
communities. 
 
Key words: Australia, fFN protein, fibronectin, relocation for birth, rural/remote pregnancy, term birth. 
 
 
 
Introduction 
 
In Australia more than 290 000 women give birth annually1. 
Approximately one-third of these women live outside major 
cities, and 3% (approximately 8000 women) live in areas 
considered remote or very remote. The availability of 
maternity services in rural and remote areas of Australia is 
declining with the closure of over 130 small rural maternity 
units since 19952. As a result, increasing numbers of pregnant 
women living in rural and remote areas relocate to give birth 
in hospitals in major cities or regional centres, often staying 
in hostels or self-care units for up to a month prior to 
birthing. The support available for these women is often 
inadequate3. In addition, some women have expressed 
concerns about the safety of their accommodation and the 
welfare of other children left behind4,5. 
 
For these women, accurately predicting the timing of birth 
would be desirable, because excluding the onset of labour in 
the near future, may provide an opportunity to delay 
relocation. However, predicting the onset of term labour and 
birth remains imprecise. Currently, determination of the 
Bishop score, an assessment of cervical status, is commonly 
used to assess suitability for induction of labour or the onset 
of imminent labour (ie within 48 hours)6. However, this is a 
subjective assessment with interobserver variability. 
 
In the context of preterm birth, tests for the detection of fetal 
fibronectin (fFN) in the cervico-vaginal secretions of women 
with symptoms of preterm labour have been recommended 
internationally for clinical practice7-9, in order to inform 
decision-making regarding the administration of antenatal 
steroids and transfer to tertiary-level units. Fetal fibronectin 
is a glyco-protein and a key component of the extracellular 
matrix of the membranes of the amniotic sac10. Disruption of 
the maternal–fetal membrane interface causes the release of 
fibronectin into cervico-vaginal secretions. The presence of 
fFN in cervico-vaginal fluid between 24 and 34 weeks of 
pregnancy is associated with impending preterm birth among 
women with symptoms of preterm labour11 and 
asymptomatic pregnant women12; however, the tests are 
most accurate in women who have symptoms. 
 
Although there is a substantial body of research about the 
assessment of fFN in the preterm setting13, there is limited 
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evidence about the accuracy of fFN testing to predict the 
onset of labour at term. Eight studies were identified that 
assessed fFN to predict term birth, and of these, three 
reported a significantly longer time-to-birth interval for 
women who tested negative for fFN compared with those in 
whom fFN was detected6,14,15. In other studies the presence of 
fFN was associated with a 91% and 96% sensitivity for 
predicting birth within 2 or 7 days of testing, respectively16,17, 
or there was no association found with the onset of term 
birth18-20. 
 
Although the literature suggests that fFN testing may be 
useful in predicting imminent term birth, it is unclear 
whether this may be a useful test to inform decisions about 
relocating rural women at term to major cities for birthing. 
Of the available studies, the majority tested women either on 
their estimated date of birth or beyond term6,14,15,19,21. 
However, this has limited relevance to the use of the test in 
rural settings with no birthing services, because it is unlikely 
that maternity providers would support women to stay at 
home after 40 weeks gestation. Here we report the results of 
a study designed to assess the accuracy of using the fFN test, 
from 37 weeks gestation, for predicting term birth among 
women living in rural and remote areas in Central and 
northern Australia. The study was designed to inform the 
possible development of a larger study evaluating the use of 
the test to determine when to transfer women into major 
cities for birthing. 
 
Methods 
 
Setting and subjects 
 
The study was undertaken in two small maternity units (with 
approximately 200 and 750 births per annum), in areas 
classified as remote districts (Australian Standard Geographic 
Classification) within the Northern Territory of Australia. 
Eligible women included those: planning to give birth at one 
of the units, aged 18 years or older, a singleton pregnancy, 
between 37+0 and 40+3 weeks (37 weeks to 40 weeks and  
3 days) gestation, and with no medical or social indication for 
induction of labour or caesarean section in the 7 days 
following recruitment. Women were not eligible to 
participate if they had any of the following: ruptured 
membranes, current vaginal bleeding or bleeding in the last 
two weeks (moderate/gross bleeding), were in active or the 
early stages of labour, cervical cerclage suture in place, 
placenta praevia or placental abruption. 
 
All eligible women birthing in the hospital, either from the 
local area of the maternity unit or those transferred in from 
very remote areas, were approached about the study. To 
assist with gaining informed consent, a DVD recording was 
developed by one of the researchers (S Kruske), and a 
registered interpreter, that included information about the 
study in the local Aboriginal language. 
 
Procedure 
 
At the antenatal visit at 37 weeks gestation (or as close as 
possible to) consenting women were invited to have a 
speculum examination and a high vaginal swab for fibronectin 
assessment. Specimen collection occurred prior to any digital 
examination or manipulation of the cervix. The fFN 
assessment was undertaken using the Quikcheck fFN test 
(Adeza Biomedical Corporation, Sunnyvale, California, 
USA). During the sterile speculum examination, a sterile 
polyester applicator tip was rotated across the posterior 
fornix of the vagina for 10 secs to absorb cervico-vaginal 
secretions. The applicator was then removed and the tip 
inserted into the Quikcheck test tube containing buffer and 
mixed vigorously for 10-15 secs. After removing as much 
liquid as possible from the applicator it was then discarded. 
The lower end of the test trip was then inserted into the 
buffer for 10 min, after which time the test strip was 
removed and the result read. 
 
After the specimen collection for fFN testing was undertaken, 
a second high vaginal swab was collected for micro culture 
and sensitivity testing. Repeat fFN testing at 7 day intervals 
was undertaken until the woman was 40+3 weeks. At the 
time of testing neither participating women nor health staff 
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other than the individual involved in performing the test were 
informed of the fFN test result. 
 
Information about women’s demographic characteristics, 
medical history and health during the current pregnancy was 
collected from medical records. The primary outcome of the 
study was the time-to-birth interval in days from the fFN test 
date. Time-to-birth was first calculated from the date of the 
first fFN test, and then separately, from the date of the last 
fFN test. In addition, the time-to-birth interval was 
categorized as either ≤ 7 days or >7 days, to assess birth 
occurring within 7 days of testing, separately for the first fFN 
test and last fFN test. Finally, also examined was the effect of 
a fFN test on time-to-birth and birth ≤ 7 days of testing for 
those women who had a test between 38+0 and 38+6 weeks, 
because this is the usual gestation at which women are 
transferred into major centres for birthing. 
 
Statistical analysis 
 
Results are expressed as mean (standard deviation [SD]), or 
number and percentage, as appropriate. Time-to-birth was 
modelled using linear regression, and separate models 
considered the effects of the results of the first fFN test, the 
last fFN test and the test undertaken at 38 weeks gestation. 
Logistic regression was used to examine the effect of the fFN 
test result on birth within 7 days of testing, separately for the 
first fFN test, last fFN test, and among tests undertaken at 38 
weeks gestation. 
 
In 52 of the fFN tests performed, lubricant was used when 
undertaking the speculum examination to collect the fFN 
swab, which can affect the accuracy of the test10. 
Accordingly, all linear and logistic regression models were 
adjusted for the use of lubricant. Similarly, all models were 
adjusted for gestational age at the time of the test (with the 
exception of the models examining the effects of tests 
undertaken at 38 weeks gestation). In addition, in the 
analyses of the last test results, the models were adjusted for 
the conduct of a previous fFN test. 
 
Four tests were found to have been undertaken outside the 
gestational age criteria (n=3 at 36+6 weeks gestation, and 
n=1 at 41+0 weeks gestation). Sensitivity analyses excluding 
these tests from the models were undertaken. All analyses 
were undertaken in Stata v10.1 (StataCorp; College Station, 
TX; USA ). A p-value <0.05 was considered statistically 
significant. 
 
Ethics approval  
 
Approval to conduct this study was obtained from the Human 
Research Ethics Committee of the Northern Territory 
Department of Health and Families and the Menzies School of 
Health Research (#HREC-07/71), and the Central 
Australian Human Research Ethics committee, and their 
relevant Aboriginal subcommittees. 
 
Results 
 
In total, 76 women were enrolled, however one woman was 
excluded from further analyses as she went into spontaneous 
labour prior to any testing being performed. Of the 
remaining 75 women participating in the study, the average 
age was 29.9 years (SD 6.2) and just over one-quarter of 
women (n=20, 27%) were nulliparous (Table 1). The 
majority of women (n=62, 83%) went into labour 
spontaneously and had a normal vaginal birth (n=65, 87%). 
The mean gestation at birth was 39+3 weeks (SD 4.6) and 
the mean birth weight of infants was 3515 g (SD 426). 
 
The number of fFN tests performed, the mean gestational age 
at each test and the result at each fFN test are described 
(Table 2). A total of 156 tests were performed. Most women 
(n=49, 65%) had more than one test performed (average 
tests 1.8, range 1-4). The mean interval from testing to birth 
according to the results of the first, last and 38 week fFN test 
is presented (Table 3). 
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Table 1: Demographic characteristics and birth outcomes, N=75 (n & % unless otherwise indicated) 
 
Characteristic/ outcome n (%)† 
Age - mean ± SD 29.9  ±  6.2 
Indigenous ethnicity 21 (28.0) 
Enrolled from Alice Springs Hospital 65 (86.7) 
Enrolled from Gove District Hospital 10 (13.3) 
Parity 
0 
1-3 
≥4 
 
20 (26.7) 
50 (66.7) 
5 (6.7) 
Bacterial vaginosis confirmed at testing 1 (1.3) 
Gestational age at delivery - mean ± SD 39.3 ± 4.6 
Labour induced 13 (17.3) 
Main indication for induction 
Post-term 
Other 
 
8 (61.5)  
5 (38.5) 
Mode of birth 
Normal vaginal birth 
Operative vaginal 
Caesarean 
 
65 (86.7) 
6 (8.0) 
3 (4.0) 
Infant birth weight - mean ± SD 3515 ± 426.0 
Infant sex: male 39 (52.0) 
Apgar score <7 at 5 min 3 (4.0)†† 
Infant admitted to special care nursery 4 (5.3) 
†Birth outcome data missing for one woman; ††Includes two fetal deaths in-utero. 
 
 
 
Table 2: Number of fFN tests undertaken, gestational age at testing and proportion of positive results 
 
Variable  No. fFN tests   
1 2 3 4 
fFN tests† -  n (%) 75 (48.1) 49 (31.4) 27 (17.3) 5 (3.2) 
Mean GA at test (weeks) 37+5 38+4 39+3 39+4 
Positive result -  n  (%) 19 (25.3) 19 (38.8) 8 (29.6) 2 (40.0) 
fFN, Fetal fibronectin; GA, gestational age. 
†Proportion of total fFN tests performed (N=156). 
 
 
 
Table 3: Mean interval from testing to birth (days) for the results of the first, last and 38 week fFN test 
 
Interval Positive fFN result Negative fFN result 
n mean (SD) n mean (SD) 
First fFN test 19 10.6 (7.1) 56 15.2 (6.9) 
Last fFN test 31 4.5 (2.6) 44 7.1 (5.5) 
38 weeks GA 17 8.9 (6.1) 43 14.6 (6.0) 
fFN, Fetal fibronectin; GA, gestational age; SD, standard deviation. 
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Mean difference (days) in time-to-birth 
 
When the analyses considered the effects of the first fFN test 
result, the unadjusted mean difference in the time-to-birth 
between women with a negative fFN test and those with a 
positive test was 4.6 days (95% confidence interval [CI] 0.9-
8.3). Adjustment for gestational age at the time of the test 
and the use of lubricant increased the mean difference 
estimate to 5.4 days (95% CI 2.0-8.8). The results were 
unchanged after the exclusion of the three tests undertaken at 
36+6 weeks. 
 
When the results were based on the last fFN test result, the 
mean difference in time-to-birth between women with a 
positive versus negative fFn test was reduced. The unadjusted 
mean difference was 2.6 days (95% CI 0.5-4.7 days), and 
adjustment for gestational age, lubricant and a previous fFN 
test increased the mean difference slightly to 2.7 days (95% 
CI 0.6-4.8). Exclusion of the test undertaken at 41+0 weeks 
did not substantially alter the results (adjusted mean different 
2.9 days, 95% CI 0.8-5.1). 
 
Birth within 7 days of testing 
 
From the time of the first fFn test, 17 women gave birth 
within 7 days, and 9 (53.0%) of these women had a positive 
result. For the 58 women who did not give birth within  
7 days, 10 women (17.2%) returned a positive result. Having 
a positive fFN test was associated with a significant increase in 
the odds of giving birth within 7 days of testing (unadjusted 
odds ratio (OR) 5.4, 95% CI 1.7-17.4). With adjustment for 
gestational age at test and lubricant use the OR increased to 
11.0 (95% CI 2.5-48.7). Exclusion of the three tests 
undertaken at 36+6 weeks did not substantially alter the 
findings (adjusted OR (AOR) 10.7, 95% CI 2.5-46.4). 
 
From the time of the last fFN test, 58 women gave birth 
within 7 days, and 29 (50.0%) of these women had a positive 
result. For the 17 women who did not birth within 7 days, 2 
(11.8%) returned a positive fFN test. Therefore, having a 
positive last fFN test was associated with significantly 
increased odds of giving birth within 7 days (unadjusted OR 
7.5, 95% CI 1.5-35.8). After adjustment for the effect of 
gestational age, lubricant use and conduct of a previous fFN 
test, the AOR associated with a positive fFN test was 8.1 
(95% CI 1.6-39.8). Exclusion of the test undertaken at 41.0 
weeks did not substantially alter the findings (AOR 8.3, 95% 
CI 1.7-41.1). 
 
Effects of tests undertaken at 38 weeks 
 
There were 60 women who had a fFN test undertaken at  
38 weeks gestation, the typical gestational age at which 
women are relocated for birthing. When the analysis set was 
restricted to these tests, the unadjusted estimated mean 
difference in time-to-birth was 5.7 days (95% CI 2.2-9.2 
days), and this was unchanged when the analyses was adjusted 
for the effect of lubricant. Among these women, 14 birthed 
within 7 days of testing, and of these 10 (71.4%) had a 
positive fFN test. In contrast, 7 (15.2%) of the 46 women 
who did not give birth within 7 days had a positive fFN test. 
Therefore, having a positive fFN test result at 38 weeks was 
associated with a significant increase in odds of birth within  
7 days (unadjusted OR 13.9, 95% CI 3.4 –57.1). After 
adjustment for the effect of lubricant use, the odds ratio 
increased slightly to 14.4 (95% CI 3.4–60.2). 
 
Discussion 
 
In this study, a positive fFN result was associated with a 
significantly shorter time-to-birth interval, and increased 
odds of giving birth within 7 days of testing when compared 
with a negative fFN result. When testing occurred at 37 or 
38 weeks gestation, women with a positive result gave birth 
approximately 5.5 days earlier than women with a negative 
test result. The results were similar when the last fFN test 
was considered, however the mean difference in time-to-
birth was diminished. These findings indicate that the 
presence of fFN in cervico-vaginal secretions at term can 
predict impending birth. 
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Although there is a paucity of research assessing the use of 
this test at term, our findings are consistent with the majority 
of available studies22. Of the four identified studies assessing 
fFN at term that report time-to-birth interval, three found a 
significantly different interval between women with a positive 
compared with a negative test result, with the mean 
difference ranging from 2.2 to 5.4 days6,14,15. 
 
Being able to accurately assess the likelihood of impending 
birth offers rural and remote dwelling pregnant women and 
their caregivers the opportunity to determine the optimal 
time to relocate to major cities for birthing. To be clinically 
useful, the fFN needs to accurately show that a negative test 
result indicates that women will not go into labour and birth 
in a rural location without access to maternity services, for a 
specified and meaningful period of time. In this study, a time 
frame of birth within 7 days of testing was chosen to assess 
whether weekly fFN testing would be accurate and feasible 
and would enable women to delay relocation for at least one 
week. Although it was found that women with a negative test 
result were significantly less likely to give birth within 7 days 
when compared with those with a positive result, a negative 
result did not reliably exclude the onset of birth. 
Approximately half of the women whose first or last test was 
negative gave birth within 7 days. Interestingly, this was less 
for the 38 week test (28.6%). Therefore, delaying relocation 
based on these test results would result in some women 
having unplanned or unprepared births in their communities, 
or an emergency evacuation back to the regional centre. 
 
Although the majority of existing studies on this topic have 
involved testing women either on their estimated date of 
birth or beyond, two studies were identified that involved 
testing at earlier gestational ages, and neither demonstrated 
conclusively that the fFN test accurately predicted the 
absence of labour. Lockwood et al showed that among 
women with a negative fFN result at 39 weeks, 63% had not 
given birth within one week of testing17. Similarly, Luton et 
al reported that when women were assessed for fFN weekly 
from 38 weeks, only 29% of women whose last fFN test was 
negative remained undelivered at 7 days after testing, 
compared with 9% of women whose last fFN test was 
positive15. 
 
The authors are aware of only one other study evaluating the 
accuracy of this test among remote dwelling women 
specifically for the purpose of allowing women to stay in their 
communities for a longer period of time23. The findings of 
this unpublished pilot study involving 17 women in Nunavut, 
Canada are consistent with the present and earlier studies, as 
more than half of all participants gave birth within 7 days of 
their last negative fFN test23. Although further research in this 
setting could be conducted to determine the accuracy of the 
test for predicting birth within a shorter time frame (eg 2 
days of testing), this is not practical in a rural setting as it 
would increase the burden of testing on women and local 
healthcare providers. It is also unclear whether delaying 
relocation for only a couple of days would be meaningful to 
the women themselves. Therefore, collectively, the current 
evidence about the accuracy of this test for excluding term 
birth does not support the use of the test to inform decisions 
related to the timing of relocation, nor does it support 
further research into this topic without modification of the 
test itself. 
 
This study has the limitation that lubricant was used to assist 
insertion of the speculum in approximately one-third of all 
tests undertaken. Lubricants can interfere with the absorption 
of the specimen onto the swab10, resulting in false negative 
test results. As a result, all analyses were adjusted for the use 
of lubricant; however, in all instances, adjustment 
strengthened the effect estimates.  
 
Conclusion 
 
Late pregnancy and birthing are very important times for any 
woman and her family. Prolonged social dislocation at this 
time in an unfamiliar environment can be extremely 
disruptive to families and carries its own risks4,5. In this study, 
although we found the presence of fFN in cervical secretions 
was associated with impending term birth, the absence of fFN 
did not reliably exclude the onset of birth, with up to 50% of 
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women with a negative fFN test giving birth within 7 days of 
testing. This indicates that testing for fFN in rural and remote 
settings would not safely allow women at term to delay 
transferring into major centres for birthing. Until services are 
improved, women in these areas will continue to be 
transferred in late pregnancy, which is suboptimal. Re-
establishment of primary maternity services in Australia’s 
rural and remote areas would be a far more satisfactory 
option, and would help to address the current inequity in 
access to appropriate maternity care experienced by rural 
women and their families. 
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